Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore P Rasmussen

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Adipocyte|August 31, 2013
Dedifferentiated adipocyte-derived progeny cells (DFAT cells): Potential stem cells of adipose tissueShengjuan Wei, Linsen Zan, Gary J Hausman, et al.
Plos One|July 23, 2013
Cholesterol-secreting and statin-responsive hepatocytes from human ES and iPS cells to model hepatic involvement in cardiovascular healthWinfried H Krueger, Borko Tanasijevic, Vanessa Barber, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 24, 2024
Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide DrugsAngela Sang, Selena Zhuo, Adara Bochanis, et al.
Stem Cells (Dayton, Ohio)|February 3, 2007
Genome-wide reprogramming in hybrids of somatic cells and embryonic stem cellsDominic J Ambrosi, Borko Tanasijevic, Anupinder Kaur, et al.
Molecular Carcinogenesis|September 13, 2007
HDAC3 overexpression and colon cancer cell proliferation and differentiationColleen C Spurling, Cassandra A Godman, Emily J Noonan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2022
Adverse Drug Reactions and Toxicity of the Food and Drug Administration-Approved Antisense Oligonucleotide DrugsFeryal Alhamadani, Kristy Zhang, Rajvi Parikh, et al.
Stem Cells (Dayton, Ohio)|June 23, 2009
ES cell cycle progression and differentiation require the action of the histone methyltransferase Dot1LEvan R Barry, Winfried Krueger, Caroline M Jakuba, et al.
Journal of Cell Science|March 24, 2005
DNA CpG hypomethylation induces heterochromatin reorganization involving the histone variant macroH2AYinghong Ma, Stephanie B Jacobs, Laurie Jackson-Grusby, et al.
Cellular Reprogramming|February 6, 2010
Rapid elimination of the histone variant MacroH2A from somatic cell heterochromatin after nuclear transferChing-Chien Chang, Shaorong Gao, Li-Ying Sung, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2022
Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration-Approved Antisense Oligonucleotide DrugsJulia M Migliorati, Sunna Liu, Anna Liu, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Adipocyte|August 31, 2013
Dedifferentiated adipocyte-derived progeny cells (DFAT cells): Potential stem cells of adipose tissueShengjuan Wei, Linsen Zan, Gary J Hausman, et al.
Plos One|July 23, 2013
Cholesterol-secreting and statin-responsive hepatocytes from human ES and iPS cells to model hepatic involvement in cardiovascular healthWinfried H Krueger, Borko Tanasijevic, Vanessa Barber, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 24, 2024
Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide DrugsAngela Sang, Selena Zhuo, Adara Bochanis, et al.
Stem Cells (Dayton, Ohio)|February 3, 2007
Genome-wide reprogramming in hybrids of somatic cells and embryonic stem cellsDominic J Ambrosi, Borko Tanasijevic, Anupinder Kaur, et al.
Molecular Carcinogenesis|September 13, 2007
HDAC3 overexpression and colon cancer cell proliferation and differentiationColleen C Spurling, Cassandra A Godman, Emily J Noonan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2022
Adverse Drug Reactions and Toxicity of the Food and Drug Administration-Approved Antisense Oligonucleotide DrugsFeryal Alhamadani, Kristy Zhang, Rajvi Parikh, et al.
Stem Cells (Dayton, Ohio)|June 23, 2009
ES cell cycle progression and differentiation require the action of the histone methyltransferase Dot1LEvan R Barry, Winfried Krueger, Caroline M Jakuba, et al.
Journal of Cell Science|March 24, 2005
DNA CpG hypomethylation induces heterochromatin reorganization involving the histone variant macroH2AYinghong Ma, Stephanie B Jacobs, Laurie Jackson-Grusby, et al.
Cellular Reprogramming|February 6, 2010
Rapid elimination of the histone variant MacroH2A from somatic cell heterochromatin after nuclear transferChing-Chien Chang, Shaorong Gao, Li-Ying Sung, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2022
Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration-Approved Antisense Oligonucleotide DrugsJulia M Migliorati, Sunna Liu, Anna Liu, et al.
Pageof 5